Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial

Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial

Announcement Highlights: Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease . The study has enrolled a total of 65 participants in the US, Europe and Australia, each of whom was...

menu
menu